drugset / Trial / NCT00927888
Postoperative Pain and Functional Patient Outcomes After Functional Endoscopic Sinus Surgery
Phase 4
Completed
56 enrolled
Stanford University
Hospira, now a wholly owned subsidiary of Pfizer · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of the study is to quantify postoperative pain after functional endoscopic sinus surgery (FESS) and investigate whether preemptive analgesia may positively impact intraoperative anesthetic management, decrease patient postoperative pain and discomfort, and improve patient functional outcomes.
Timeline
- Start
- 2007-08
- Primary completion
- 2010-03
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 0.25 % | Other |
| Comparator | Bupivacaine | Other / unclassified | 2 ml | Other |